<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0004-0622</journal-id>
<journal-title><![CDATA[Archivos Latinoamericanos de Nutrición]]></journal-title>
<abbrev-journal-title><![CDATA[ALAN]]></abbrev-journal-title>
<issn>0004-0622</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Latinoamericana de Nutrición]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0004-06222008000100002</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Prevalence of anemia and deficiencies of iron, folic acid and vitamin B12 in an Indigenous community from the Venezuelan Amazon with a high incidence of malaria]]></article-title>
<article-title xml:lang="es"><![CDATA[Prevalencia de anemia y deficiencias de hierro, ácido fólico y vitamina B12 en una comunidad indígena del Amazonas Venezolano con alta incidencia de malaria]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[García-Casal]]></surname>
<given-names><![CDATA[Maria Nieves]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Leets]]></surname>
<given-names><![CDATA[Irene]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Bracho]]></surname>
<given-names><![CDATA[Carmen]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Hidalgo]]></surname>
<given-names><![CDATA[Mariana]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Bastidas]]></surname>
<given-names><![CDATA[Gilberto]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Gomez]]></surname>
<given-names><![CDATA[Ana]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Peña]]></surname>
<given-names><![CDATA[Ana]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pérez]]></surname>
<given-names><![CDATA[Hilda]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
</contrib-group>
<aff id="A01">
<institution><![CDATA[,Instituto Venezolano de Investigaciones Científicas IVIC  ]]></institution>
<addr-line><![CDATA[Caracas ]]></addr-line>
<country>Venezuela</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>03</month>
<year>2008</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>03</month>
<year>2008</year>
</pub-date>
<volume>58</volume>
<numero>1</numero>
<fpage>12</fpage>
<lpage>18</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://ve.scielo.org/scielo.php?script=sci_arttext&amp;pid=S0004-06222008000100002&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://ve.scielo.org/scielo.php?script=sci_abstract&amp;pid=S0004-06222008000100002&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://ve.scielo.org/scielo.php?script=sci_pdf&amp;pid=S0004-06222008000100002&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[The objective of this work was to determine the prevalence of anemia and deficiencies of iron, folic acid and vitamin B12 in Betania del Topocho, a Piaroa community from Estado Amazonas, Venezuela, a zone with a high incidence of malaria. The group studied included 184 subjects of all ages that assisted to the local health center for malaria diagnosis. Analysis performed included hematology by coulter counter, ferritin quantification by ELISA with monoclonal antibodies and folic acid and vitamin B12 determinations by an immunoradiometric assay. It was found that the prevalence of anemia was 89.6% and deficiencies of iron, folic acid and vitamin B12 affected 37.1, 70.3 and 12.4% of the population studied, respectively. Plasmodium infection was detected by molecular diagnosis in 53.2% of the cases, and 86% of them were anemic. The highest incidence of anemia was found in children, with a prevalence of 100% in infants of both sexes. The high prevalence of anemia, iron and folic acid deficiencies found, indicates an important health and nutrition problem that should be immediately and properly addressed. The number of cases of anemia due to iron deficiency could be underestimated, since ferritin concentration increased as a acute phase protein, although prevalence data was also analyzed with a cutoff point of 30 &#956;g/L for ferritin concentration.]]></p></abstract>
<abstract abstract-type="short" xml:lang="es"><p><![CDATA[El objetivo de este trabajo fue estudiar la prevalencia de anemia y de las deficiencias de hierro, ácido fólico y vitamina B12 en Betania del Topocho, población indígena de la etnia Piaroa, del Estado Amazonas, Venezuela, una zona con alta incidencia de malaria. Se estudiaron 184 sujetos de todas las edades que asistieron al Centro de salud para despistaje de malaria. Se realizó hematología completa por Coulter counter, la cuantificación de ferritina por ELISA con anticuerpos monoclonales, y la determinación de ácido fólico y vitamina B12 séricas por un ensayo inmunoradiométrico. La prevalencia de anemia fue de 89.6% y las deficiencias de hierro, ácido fólico y vitamina B12 afectaron 37.1, 70.3 y 12.4% de la población estudiada, respectivamente. La infección con Plasmodium fue detectada por diagnóstico molecular en el 53.2% de los casos, y 86% de ellos eran anémicos. La mayor incidencia de anemia fue encontrada en niños, con una prevalencia del 100% en lactantes de ambos sexos. La alta prevalencia de anemia y deficiencias de hierro y ácido fólico indican un problema de salud y de nutrición importante en esta comunidad que debe ser tratada de forma adecuada y urgente. Los casos de anemia debidos a deficiencia de hierro, podrían estar siendo subestimados, ya que la ferritina sérica es también una proteína de fase aguda que aumenta en caso de infección, aunque los datos de prevalencia fueron también analizados con un punto de corte de 30 &#956;g/L para la concentración de ferritina.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[Anemia]]></kwd>
<kwd lng="en"><![CDATA[iron deficiency]]></kwd>
<kwd lng="en"><![CDATA[folic acid]]></kwd>
<kwd lng="en"><![CDATA[malaria]]></kwd>
<kwd lng="en"><![CDATA[Indians]]></kwd>
<kwd lng="es"><![CDATA[Anemia]]></kwd>
<kwd lng="es"><![CDATA[deficiencia de hierro]]></kwd>
<kwd lng="es"><![CDATA[ácido fólico]]></kwd>
<kwd lng="es"><![CDATA[malaria]]></kwd>
<kwd lng="es"><![CDATA[indígenas]]></kwd>
</kwd-group>
</article-meta>
</front><body><![CDATA[   <b>     <p ALIGN="center"><font color="#231f20" face="Verdana" size="3">Prevalence of anemia and deficiencies of iron, folic acid</font></b>  <b> <font color="#231f20" face="Verdana" size="3">and vitamin B</font><font face="Verdana" size="3" color="#231F20"><sub>12</sub></font> <font color="#231f20" face="Verdana" size="3"> in an Indigenous community</font> </b> <b><font color="#231f20" face="Verdana" size="3">from the Venezuelan Amazon with a high incidence of malaria</font></p> </b>     <p ALIGN="center"><b><font COLOR="#231f20" size="2" face="Verdana">Maria Nieves García-Casal, Irene Leets, Carmen Bracho, Mariana Hidalgo, Gilberto Bastidas,</font> <font COLOR="#231f20" size="2" face="Verdana">Ana Gomez, Ana Peña, Hilda Pérez</font></b></p>     <p ALIGN="justify"><font COLOR="#231f20" size="2" face="Verdana">Instituto Venezolano de Investigaciones Científicas (IVIC), Centros de: Medicina Experimental y Microbiología</font> <font COLOR="#231f20" size="2" face="Verdana">y Biología Celular. Caracas, Venezuela. Hospital “José Gregorio Hernández” de Puerto Ayacucho, Amazonas, Venezuela</font></p> <b>     <p ALIGN="justify"><font COLOR="#231f20" face="Verdana" size="2">SUMMARY. </font></b></p>     <p ALIGN="justify"><font COLOR="#231f20" face="Verdana" size="2">The objective of this work was to determine the prevalence</font> <font COLOR="#231f20" face="Verdana" size="2">of anemia and deficiencies of iron, folic acid and vitamin B12</font> <font COLOR="#231f20" face="Verdana" size="2">in Betania del Topocho, a Piaroa community from Estado Amazonas,</font> <font COLOR="#231f20" face="Verdana" size="2">Venezuela, a zone with a high incidence of malaria. The group studied</font> <font COLOR="#231f20" face="Verdana" size="2">included 184 subjects of all ages that assisted to the local health</font> <font COLOR="#231f20" face="Verdana" size="2">center for malaria diagnosis. Analysis performed included hematology</font> <font COLOR="#231f20" face="Verdana" size="2">by coulter counter, ferritin quantification by ELISA with monoclonal</font> <font COLOR="#231f20" face="Verdana" size="2">antibodies and folic acid and vitamin B12 determinations by</font> <font COLOR="#231f20" face="Verdana" size="2">an immunoradiometric assay. It was found that the prevalence of</font> <font COLOR="#231f20" face="Verdana" size="2">anemia was 89.6% and deficiencies of iron, folic acid and vitamin</font> <font COLOR="#231f20" face="Verdana" size="2">B12 affected 37.1, 70.3 and 12.4% of the population studied, respectively.</font> <i><font COLOR="#231f20" face="Verdana" size="2">Plasmodium </font></i><font COLOR="#231f20" face="Verdana" size="2">infection was detected by molecular diagnosis</font> <font COLOR="#231f20" face="Verdana" size="2">in 53.2% of the cases, and 86% of them were anemic. The highest</font> <font COLOR="#231f20" face="Verdana" size="2">incidence of anemia was found in children, with a prevalence of</font> <font COLOR="#231f20" face="Verdana" size="2">100% in infants of both sexes. The high prevalence of anemia, iron</font> <font COLOR="#231f20" face="Verdana" size="2">and folic acid deficiencies found, indicates an important health and</font> <font COLOR="#231f20" face="Verdana" size="2">nutrition problem that should be immediately and properly addressed.</font></p>     <p ALIGN="justify"><font COLOR="#231f20" size="2" face="Verdana">The number of cases of anemia due to iron deficiency could be</font> <font COLOR="#231f20" size="2" face="Verdana">underestimated, since ferritin concentration increased as a acute phase</font> <font COLOR="#231f20" size="2" face="Verdana">protein, although prevalence data was also analyzed with a cutoff</font> <font COLOR="#231f20" size="2" face="Verdana">point of 30 &#956;g/L for ferritin concentration.</font></p> <b>     <p ALIGN="justify"><font COLOR="#231f20" face="Verdana" size="2">Key words: </font></b><font COLOR="#231f20" face="Verdana" size="2">Anemia, iron deficiency, folic acid, malaria, Indians.</font></p> <b>     <p ALIGN="center"><font COLOR="#231f20" size="2" face="Verdana"> Prevalencia de anemia y deficiencias de hierro, ácido</font></b>  <b> <font COLOR="#231f20" size="2" face="Verdana">fólico y vitamina B</font><font face="Verdana" size="2" color="#231F20"><sub>12</sub></font> <font COLOR="#231f20" size="2" face="Verdana"> en una comunidad indígena del Amazonas</font> </b> <font COLOR="#231f20" size="2" face="Verdana"><b>Venezolano con alta incidencia de malaria&nbsp; </b></font></p>     <p ALIGN="justify"><font color="#231f20" size="2" face="Verdana"><b>RESUMEN.</b></font></p>     ]]></body>
<body><![CDATA[<p ALIGN="justify"><font COLOR="#231f20" face="Verdana" size="2">El objetivo de este</font> <font COLOR="#231f20" face="Verdana" size="2">trabajo fue estudiar la prevalencia de anemia y de las deficiencias de</font> <font COLOR="#231f20" face="Verdana" size="2">hierro, ácido fólico y vitamina B</font><font face="Verdana" size="2" color="#231F20"><sub>12</sub></font> <font COLOR="#231f20" face="Verdana" size="2"> en Betania del Topocho, población</font> <font COLOR="#231f20" face="Verdana" size="2">indígena de la etnia Piaroa, del Estado Amazonas, Venezuela, una zona</font> <font COLOR="#231f20" face="Verdana" size="2">con alta incidencia de malaria. Se estudiaron 184 sujetos de todas las</font> <font COLOR="#231f20" face="Verdana" size="2">edades que asistieron al Centro de salud para despistaje de malaria. Se</font> <font COLOR="#231f20" face="Verdana" size="2">realizó hematología completa por Coulter counter, la cuantificación de</font> <font COLOR="#231f20" face="Verdana" size="2">ferritina por ELISA con anticuerpos monoclonales, y la determinación</font> <font COLOR="#231f20" face="Verdana" size="2">de ácido fólico y vitamina B</font><font face="Verdana" size="2" color="#231F20"><sub>12 </sub></font> <font COLOR="#231f20" face="Verdana" size="2"> séricas por un ensayo</font> <font COLOR="#231f20" face="Verdana" size="2">inmunoradiométrico. La prevalencia de anemia fue de 89.6% y las</font> <font COLOR="#231f20" face="Verdana" size="2">deficiencias de hierro, ácido fólico y vitamina B</font><font face="Verdana" size="2" color="#231F20"><sub>12 </sub></font> <font COLOR="#231f20" face="Verdana" size="2"> afectaron 37.1, 70.3</font> <font COLOR="#231f20" face="Verdana" size="2">y 12.4% de la población estudiada, respectivamente. La infección con</font> <i><font COLOR="#231f20" face="Verdana" size="2">Plasmodium </font></i><font COLOR="#231f20" face="Verdana" size="2">fue detectada por diagnóstico molecular en el 53.2% de</font> <font COLOR="#231f20" face="Verdana" size="2">los casos, y 86% de ellos eran anémicos. La mayor incidencia de</font> <font COLOR="#231f20" face="Verdana" size="2">anemia fue encontrada en niños, con una prevalencia del 100% en</font> <font COLOR="#231f20" face="Verdana" size="2">lactantes de ambos sexos. La alta prevalencia de anemia y deficiencias</font> <font COLOR="#231f20" face="Verdana" size="2">de hierro y ácido fólico indican un problema de salud y de nutrición</font> <font COLOR="#231f20" face="Verdana" size="2">importante en esta comunidad que debe ser tratada de forma adecuada</font> <font COLOR="#231f20" face="Verdana" size="2">y urgente. Los casos de anemia debidos a deficiencia de hierro, podrían</font> <font COLOR="#231f20" face="Verdana" size="2">estar siendo subestimados, ya que la ferritina sérica es también una</font> <font COLOR="#231f20" face="Verdana" size="2">proteína de fase aguda que aumenta en caso de infección, aunque los</font> <font COLOR="#231f20" face="Verdana" size="2">datos de prevalencia fueron también analizados con un punto de corte</font> <font COLOR="#231f20" face="Verdana" size="2">de 30 &#956;g/L para la concentración de ferritina.</font></p> <b>     <p ALIGN="justify"><font COLOR="#231f20" face="Verdana" size="2">Palabras clave: </font></b><font face="Verdana" size="2"><font COLOR="#231f20">Anemia, deficiencia de hierro, ácido fólico, malaria,</font> <font COLOR="#231f20">indígenas.</font></font></p>     <p ALIGN="justify"><font face="Verdana" size="2"><b><font COLOR="#231f20">Recibido:</font></b><font COLOR="#231f20"> 01-11-2007</font> <font COLOR="#231f20"><b>Aceptado: </b>17-01-2008</font></font></p> <b>     <p ALIGN="justify"><font COLOR="#231f20" size="2" face="Verdana">INTRODUCTION</font></p> </b>     <p ALIGN="justify"><font COLOR="#231f20" size="2" face="Verdana">Anemia and iron deficiency constitute the most frequent</font> <font COLOR="#231f20" size="2" face="Verdana">nutritional problems worldwide. Some age groups are more</font> <font COLOR="#231f20" size="2" face="Verdana">vulnerable to suffer this deficiency, especially as a consequence</font> <font COLOR="#231f20" size="2" face="Verdana">of increased requirements and/or losses of the mineral. For</font> <font COLOR="#231f20" size="2" face="Verdana">this reason infants, preschoolers and pregnant and childbearing</font> <font COLOR="#231f20" size="2" face="Verdana">age women are more susceptible to iron deficiency (1,2).</font> <font COLOR="#231f20" size="2" face="Verdana">Folic acid is required for some vital functions such as the synthesis</font> <font COLOR="#231f20" size="2" face="Verdana">of nucleic acids, blood cells and neural tissue. Also, it</font> <font COLOR="#231f20" size="2" face="Verdana">has an important role in the synthesis of methionine and as a</font> <font COLOR="#231f20" size="2" face="Verdana">precursor of SAM (S-adenosyl methionine), universal donor</font> <font COLOR="#231f20" size="2" face="Verdana">of methyl groups for more than 100 organic reactions (3,4).</font> <font COLOR="#231f20" size="2" face="Verdana">Folic acid deficiency is very prevalent in the world and some</font> <font COLOR="#231f20" size="2" face="Verdana">consequences of this deficiency include: macrocitic or megaloblastic</font> <font COLOR="#231f20" size="2" face="Verdana">anemia, increased incidence or severity of some types</font> <font COLOR="#231f20" size="2" face="Verdana">of cancer (5-7), neural tube defects (8,9), increased serum</font> <font COLOR="#231f20" size="2" face="Verdana">homocysteine levels and cardiovascular alterations (10-12).</font> <font COLOR="#231f20" size="2" face="Verdana">has an important role in the synthesis of methionine and as a</font> <font COLOR="#231f20" size="2" face="Verdana">precursor of SAM (S-adenosyl methionine), universal donor</font> <font COLOR="#231f20" size="2" face="Verdana">of methyl groups for more than 100 organic reactions (3,4).</font> <font COLOR="#231f20" size="2" face="Verdana">Folic acid deficiency is very prevalent in the world and some</font> <font COLOR="#231f20" size="2" face="Verdana">consequences of this deficiency include: macrocitic or megaloblastic</font> <font COLOR="#231f20" size="2" face="Verdana">anemia, increased incidence or severity of some types</font> <font COLOR="#231f20" size="2" face="Verdana">of cancer (5-7), neural tube defects (8,9), increased serum</font> <font COLOR="#231f20" size="2" face="Verdana">homocysteine levels and cardiovascular alterations (10-12).</font> </p>     <p ALIGN="justify"><font COLOR="#231f20" size="2" face="Verdana">On the other hand, Vitamin B</font><font face="Verdana" size="2" color="#231F20"><sub>12</sub></font><font COLOR="#231f20" size="2" face="Verdana"> deficiency is less common</font> <font COLOR="#231f20" size="2" face="Verdana">and usually affects elderly people and strict vegetarians (3,13).</font> <font COLOR="#231f20" size="2" face="Verdana">Deficiency of this vitamin is recognized for its effect on</font> <font COLOR="#231f20" size="2" face="Verdana">hematopoyetic and neural systems, causing an important impairment</font> <font COLOR="#231f20" size="2" face="Verdana">of DNA replication, producing irreversible neuropathy</font> <font COLOR="#231f20" size="2" face="Verdana">and discontinuous, diffuse and progressive nerve</font> <font COLOR="#231f20" size="2" face="Verdana">demielinization (14,15).</font> </p>     <p ALIGN="justify"><font COLOR="#231f20" size="2" face="Verdana">Nutritional information, and especially on prevalence of</font> <font COLOR="#231f20" size="2" face="Verdana">anemia and deficiencies of iron, folic acid and vitamin B</font><font face="Verdana" size="2" color="#231F20"><sub>12</sub></font><font COLOR="#231f20" size="2" face="Verdana">, is</font> <font COLOR="#231f20" size="2" face="Verdana">scarce in Indigenous populations living far from big cities. In</font> <font COLOR="#231f20" size="2" face="Verdana">Venezuela, this is valid even in some Indigenous communities</font> <font COLOR="#231f20" size="2" face="Verdana">partially or totally incorporated to the same level of development</font> <font COLOR="#231f20" size="2" face="Verdana">achieved in the rest of the country. That is the case of the</font> <font COLOR="#231f20" size="2" face="Verdana">Piaroa community studied in this work, which is located in close</font> <font COLOR="#231f20" size="2" face="Verdana">proximity to a populated center and has adapted to some urban</font> <font COLOR="#231f20" size="2" face="Verdana">costumes, while preserving some ancestral traditions and habits.</font> <font COLOR="#231f20" size="2" face="Verdana">The socioeconomic situation and the difficulties to access</font> <font COLOR="#231f20" size="2" face="Verdana">services associated with urban centers (i.e. year round supply of</font> <font COLOR="#231f20" size="2" face="Verdana">varied food sources), as well as religious or cultural practices,</font> <font COLOR="#231f20" size="2" face="Verdana">may act in some cases as factors that increase the probability of</font> <font COLOR="#231f20" size="2" face="Verdana">anemia, iron deficiency and in general, malnutrition.</font></p>     <p ALIGN="justify"><font COLOR="#231f20" size="2" face="Verdana">The objective of this work was to determine the prevalence of</font> <font COLOR="#231f20" size="2" face="Verdana">anemia and deficiencies of iron, folic acid and vitamin B</font><font face="Verdana" size="2" color="#231F20"><sub>12 </sub></font> <font COLOR="#231f20" size="2" face="Verdana"> in Betania</font> <font COLOR="#231f20" size="2" face="Verdana">del Topocho, a rural Piaroa community, located in close proximity</font> <font COLOR="#231f20" size="2" face="Verdana">to Puerto Ayacucho capital city of the Amazonas State in Venezuela.</font> <font COLOR="#231f20" size="2" face="Verdana">This is a region with a high prevalence of malaria.</font></p> <b>     <p ALIGN="justify"><font COLOR="#231f20" size="2" face="Verdana">MATERIALS AND METHODS</font></p> </b>     <p ALIGN="justify"><font COLOR="#231f20" size="2" face="Verdana">According to the information provided by the Venezuelan</font> <font COLOR="#231f20" size="2" face="Verdana">National Institute of Statistics and based on projections from</font> <font COLOR="#231f20" size="2" face="Verdana">2001 Venezuelan population census, the Amazonas State population</font> <font COLOR="#231f20" size="2" face="Verdana">during 2005 was 134,594 (16). The community studied</font> <font COLOR="#231f20" size="2" face="Verdana">named Betania del Topocho, belongs to the Atures Municipality</font> <font COLOR="#231f20" size="2" face="Verdana">and is located 50 kilometers north of Puerto Ayacucho,</font> <font COLOR="#231f20" size="2" face="Verdana">the capital city of the state. At the time of the study, the community</font> <font COLOR="#231f20" size="2" face="Verdana">consisted of 500 Piaroa individuals living in individual</font> <font COLOR="#231f20" size="2" face="Verdana">houses (one per family), which differ from the traditional communal</font> <font COLOR="#231f20" size="2" face="Verdana">house typical of the Piaroa people. The community</font> <font COLOR="#231f20" size="2" face="Verdana">has access to electricity and water services, markets, a rural</font> <font COLOR="#231f20" size="2" face="Verdana">medical facility attended by a nurse and one elementary school</font> <font COLOR="#231f20" size="2" face="Verdana">(17). The Piaroa ethnia represents approximately 3% of all</font> <font COLOR="#231f20" size="2" face="Verdana">indigenous population in Venezuela.</font></p>     ]]></body>
<body><![CDATA[<p ALIGN="justify"><font COLOR="#231f20" size="2" face="Verdana">Sample collection was performed in the community medical</font> <font COLOR="#231f20" size="2" face="Verdana">facility and our research team was accompanied by a representative</font> <font COLOR="#231f20" size="2" face="Verdana">of the Ministry of Health who was collecting</font> <font COLOR="#231f20" size="2" face="Verdana">samples for malaria diagnosis. The sampling process was carried</font> <font COLOR="#231f20" size="2" face="Verdana">out during 3 consecutive days, and each individual, including</font> <font COLOR="#231f20" size="2" face="Verdana">parents or guardians for children and adolescents under</font> <font COLOR="#231f20" size="2" face="Verdana">18 years of age, was informed, using interpreters, about</font> <font COLOR="#231f20" size="2" face="Verdana">the objectives of the study. Each individual was informed that</font> <font COLOR="#231f20" size="2" face="Verdana">participation consisted in donating a blood sample to determine</font> <font COLOR="#231f20" size="2" face="Verdana">hemoglobin, ferritin, folic acid and vitamin B</font><font face="Verdana" size="2" color="#231F20"><sub>12</sub></font> <font COLOR="#231f20" size="2" face="Verdana"> concentrations</font> <font COLOR="#231f20" size="2" face="Verdana">and that the results would be informed to each</font> <font COLOR="#231f20" size="2" face="Verdana">participant. They were informed that data on gender, age,</font> <font COLOR="#231f20" size="2" face="Verdana">height and weight, was also required.</font></p>     <p ALIGN="justify"><font COLOR="#231f20" size="2" face="Verdana">In the community studied most individuals speak only</font> <font COLOR="#231f20" size="2" face="Verdana">Piaroa and we contacted 2 members of the community who</font> <font COLOR="#231f20" size="2" face="Verdana">spoke Spanish and acted as interpreters. Information about</font> <font COLOR="#231f20" size="2" face="Verdana">the study was exchanged with participants, fluently and without</font> <font COLOR="#231f20" size="2" face="Verdana">problems.</font></p>     <p ALIGN="justify"><font COLOR="#231f20" size="2" face="Verdana">The sample consisted in 208 individuals of both sexes and</font> <font COLOR="#231f20" size="2" face="Verdana">ages between 1 and 94 years, which represents 41.6% of the</font> <font COLOR="#231f20" size="2" face="Verdana">total population of the community, based on data from 2001</font> <font COLOR="#231f20" size="2" face="Verdana">National Census. Sample was taken from all individuals that</font> <font COLOR="#231f20" size="2" face="Verdana">attended the medical facility because they knew about our</font> <font COLOR="#231f20" size="2" face="Verdana">presence in the community and consented to participate in</font> <font COLOR="#231f20" size="2" face="Verdana">the study. Since it was a self-selected sample, the age and</font> <font COLOR="#231f20" size="2" face="Verdana">gender distribution of the sample was compared against the</font> <font COLOR="#231f20" size="2" face="Verdana">indigenous communities of Amazonas State.</font></p>     <p ALIGN="justify"><font COLOR="#231f20" size="2" face="Verdana">Blood samples were taken from the antecubital vein of</font> <font COLOR="#231f20" size="2" face="Verdana">the arm, after proper antisepsis, with alcohol and sterile cotton</font> <font COLOR="#231f20" size="2" face="Verdana">swabs. The content of the syringe was distributed in 2</font> <font COLOR="#231f20" size="2" face="Verdana">tubes: with or without ethylene diamino tetra acetic acid</font> <font COLOR="#231f20" size="2" face="Verdana">(EDTA) as anticoagulant. Determinations of hemoglobin concentration</font> <font COLOR="#231f20" size="2" face="Verdana">were performed in a Coulter Counter in the Laboratory</font> <font COLOR="#231f20" size="2" face="Verdana">of the hospital “Jose Gregorio Hernández” at Puerto</font> <font COLOR="#231f20" size="2" face="Verdana">Ayacucho, the capital city of the State. Samples in tubes without</font> <font COLOR="#231f20" size="2" face="Verdana">anticoagulant were centrifuged 2 to 4 hours after collection,</font> <font COLOR="#231f20" size="2" face="Verdana">the serum was separated, aliquoted, and frozen at –20ºC</font> <font COLOR="#231f20" size="2" face="Verdana">until use for serum iron (18), unsaturated iron binding capacity</font> <font COLOR="#231f20" size="2" face="Verdana">(UIBC) (19), total iron binding capacity (TIBC) (19), ferritin,</font> <font COLOR="#231f20" size="2" face="Verdana">folic acid and vitamin B</font><font face="Verdana" size="2" color="#231F20"><sub>12 </sub></font> <font COLOR="#231f20" size="2" face="Verdana"> determinations.</font> <font COLOR="#231f20" size="2" face="Verdana">Serum ferritin concentration was determined by an ELISA</font> <font COLOR="#231f20" size="2" face="Verdana">(Enzyme linked immunosorbent assay) (20), developed in our</font> <font COLOR="#231f20" size="2" face="Verdana">laboratory using monoclonal antibodies raised against human</font> <font COLOR="#231f20" size="2" face="Verdana">ferritin. Intra and inter-assay variation is 5 and 7%, respectively</font> <font COLOR="#231f20" size="2" face="Verdana">and the assay has been validated against International</font> <font COLOR="#231f20" size="2" face="Verdana">standards. Also, internal controls of known concentration (low,</font> <font COLOR="#231f20" size="2" face="Verdana">medium and high) are run in each plate.</font></p>     <p ALIGN="justify"><font face="Verdana" size="2"><font COLOR="#231f20">Serum folic acid and vitamin B</font></font><font face="Verdana" size="2" color="#231F20"><sub>12</sub></font><font COLOR="#231f20">  </font> <font face="Verdana" size="2"> determinations were performed in a sub s</font><font COLOR="#231f20" size="2" face="Verdana">ample by a radio immunoassay from DPC</font> <font COLOR="#231f20" size="2" face="Verdana">(Diagnostic Product Corporation, Los Angeles, California)</font> <font COLOR="#231f20" size="2" face="Verdana">(21), which contains a high affinity folate-binding protein from</font> <font COLOR="#231f20" size="2" face="Verdana">milk to measure folic acid, and intrinsic factor purified from</font> <font COLOR="#231f20" size="2" face="Verdana">hog to measure vitamin B</font><font face="Verdana" size="2" color="#231F20"><sub>12 </sub></font> <font COLOR="#231f20" size="2" face="Verdana"> by competitive binding. It is a</font> <font COLOR="#231f20" size="2" face="Verdana">radioactive method non susceptible to antibiotics and</font> <font COLOR="#231f20" size="2" face="Verdana">metothrexate that allows the simultaneous determination of</font> <font COLOR="#231f20" size="2" face="Verdana">folic acid and vitamin B12 concentrations in serum, plasma</font> <font COLOR="#231f20" size="2" face="Verdana">or blood, which can be calculated from standard curves.</font> <font COLOR="#231f20" size="2" face="Verdana">Anemia was diagnosed when hemoglobin concentration</font> <font COLOR="#231f20" size="2" face="Verdana">was &lt; 11 g/L in children less than 4 years, &lt;11.5 g/L in children</font> <font COLOR="#231f20" size="2" face="Verdana">4 to 10.9 years, &lt;12 g/L for all non-pregnant women</font> <font COLOR="#231f20" size="2" face="Verdana">older than 11 years of age, &lt;11 g/L for pregnant women, &lt;12.5</font> <font COLOR="#231f20" size="2" face="Verdana">for boys 11 to 12.9 years and &lt; 13 for men older than 13</font> <font COLOR="#231f20" size="2" face="Verdana">years. The cutoff points used for iron deficiency were serum</font> <font COLOR="#231f20" size="2" face="Verdana">ferritin concentrations &lt;10 &#956;g/L for individuals less than 14</font> <font COLOR="#231f20" size="2" face="Verdana">years old and &lt;12 &#956;g/L for the rest of the age groups. Since</font></p>     <p ALIGN="justify"><font COLOR="#231f20" size="2" face="Verdana">there was an important prevalence of malaria and infections</font> <font COLOR="#231f20" size="2" face="Verdana">in general, ferritin data was also analyzed using a cutoff point</font> <font COLOR="#231f20" size="2" face="Verdana">of 30 &#956;g/L, as suggested by WHO (2).</font> <font COLOR="#231f20" size="2" face="Verdana">The cutoff points used for serum folic acid were &lt;3 ng/mL</font> <font COLOR="#231f20" size="2" face="Verdana">for severe deficiency, and 3 to 6 ng/mL for moderate deficiency.</font></p>     <p ALIGN="justify"><font face="Verdana" size="2"><font COLOR="#231f20">Vitamin B</font></font><font face="Verdana" size="2" color="#231F20"><sub>12</sub></font><font COLOR="#231f20">, deficiency was defined as serum concentration</font> <font COLOR="#231f20" size="2" face="Verdana">below 200 pg/mL, normality range varied from 200 to 900 pg/</font> <font COLOR="#231f20" size="2" face="Verdana">ml and excess &gt;900 pg/mL (3, 21). Unless otherwise indicated,</font> <font COLOR="#231f20" size="2" face="Verdana">prevalence of folic acid deficiency refers to cases with severe</font> <font COLOR="#231f20" size="2" face="Verdana">and moderate deficiency, with a cutoff point &lt;6 ng/ml.</font> <font COLOR="#231f20" size="2" face="Verdana">Analyses of results were performed calculating the prevalence</font> <font COLOR="#231f20" size="2" face="Verdana">of anemia and deficiencies of iron, folic acid and vitamin</font> <font COLOR="#231f20" size="2" face="Verdana">B</font><font face="Verdana" size="2" color="#231F20"><sub>12</sub></font> <font COLOR="#231f20" size="2" face="Verdana"> separately and then correlating these deficiencies as</font> <font COLOR="#231f20" size="2" face="Verdana">causes of anemia, according to age and gender. ANOVA with</font> <font COLOR="#231f20" size="2" face="Verdana">Bonferroni as a post-test was used to compare differences in</font> <font COLOR="#231f20" size="2" face="Verdana">biochemical variables by age and gender.</font></p> <b>     <p ALIGN="justify"><font COLOR="#231f20" size="2" face="Verdana">RESULTS</font></p> </b>     <p ALIGN="justify"><font COLOR="#231f20" size="2" face="Verdana">The population studied included subjects of all ages and</font> <font COLOR="#231f20" size="2" face="Verdana">gender that assisted to the community medical facility for diagnosis</font> <font COLOR="#231f20" size="2" face="Verdana">of malaria and consented to participate in the study.</font> <font COLOR="#231f20" size="2" face="Verdana">Since the sample was self-selected and we did not have access</font> <font COLOR="#231f20" size="2" face="Verdana">to the community age and gender distribution, the comparison</font> <font COLOR="#231f20" size="2" face="Verdana">was performed against the indigenous communities</font> <font COLOR="#231f20" size="2" face="Verdana">of Amazonas State. Regarding age, distribution was similar</font> <font COLOR="#231f20" size="2" face="Verdana">in both locations: 10.4 and 10.5% for 1-3 years old children,</font> <font COLOR="#231f20" size="2" face="Verdana">29.7 and 24.1% for 4-10 years, 17.6 and 22.3 for 11-20 years,</font> <font COLOR="#231f20" size="2" face="Verdana">28.6 and 28.0 for 21-40 years and 13.7 and 15.1% for 41 and</font> <font COLOR="#231f20" size="2" face="Verdana">more years, in the community and the State respectively. Gender</font> <font COLOR="#231f20" size="2" face="Verdana">distribution in the community presented a predominance</font> <font COLOR="#231f20" size="2" face="Verdana">in females and was different from the State: 58.8% females</font> <font COLOR="#231f20" size="2" face="Verdana">and 41.2% males for the community and 48.2% females and</font> <font COLOR="#231f20" size="2" face="Verdana">51.8% males for the Amazonas State.</font></p>     <p ALIGN="justify"><font COLOR="#231f20" size="2" face="Verdana">As shown in <a href="#tab1"> Table 1</a> the hematological evaluation of the</font> <font COLOR="#231f20" size="2" face="Verdana">whole group and classified by gender, revealed an anemic</font> <font COLOR="#231f20" size="2" face="Verdana">population with a mean hemoglobin concentration of 10.61</font> <font COLOR="#231f20" size="2" face="Verdana">g/L. Biochemical parameters for measuring iron metabolism</font> <font COLOR="#231f20" size="2" face="Verdana">of the individuals, showed low levels for serum iron and transferrin</font> <font COLOR="#231f20" size="2" face="Verdana">saturation, as well as for UIBC and TIBC. Iron stores,</font> <font COLOR="#231f20" size="2" face="Verdana">measured by serum ferritin concentration, are slightly above</font> <font COLOR="#231f20" size="2" face="Verdana">the cutoff point for iron deficiency of 12 &#956;g/L, being classified</font> <font COLOR="#231f20" size="2" face="Verdana">as a moderately iron deficient population. Also, serum</font> <font COLOR="#231f20" size="2" face="Verdana">folic acid levels revealed a moderately deficient population.</font></p>     ]]></body>
<body><![CDATA[<p ALIGN="justify"><font COLOR="#231f20" size="2" face="Verdana">The only nutritional parameter evaluated that showed adequate</font> <font COLOR="#231f20" size="2" face="Verdana">serum levels at population level, was vitamin B</font><font face="Verdana" size="2" color="#231F20"><sub>12</sub></font><font COLOR="#231f20" size="2" face="Verdana">, with a mean</font> <font COLOR="#231f20" size="2" face="Verdana">concentration of 592.6 pg/mL, considerably above the cutoff</font> <font COLOR="#231f20" size="2" face="Verdana">point for deficiency of 200 pg/mL.</font></p>     <p ALIGN="center"><a name="tab1"><img border="0" src="/img/fbpe/alan/v58n1/art02tab1.jpg" width="492" height="421"></a></p>     
<p ALIGN="justify"><font COLOR="#231f20" size="2" face="Verdana">Population studied was classified by age and gender, showing</font> <font COLOR="#231f20" size="2" face="Verdana">that all groups presented borderline or deficiency values</font> <font COLOR="#231f20" size="2" face="Verdana">for hemoglobin, ferritin and folic acid.</font> <font COLOR="#231f20" size="2" face="Verdana">Children in general, especially infants less than 3 years</font> <font COLOR="#231f20" size="2" face="Verdana">old, presented the lowest levels for hemoglobin and ferritin</font> <font COLOR="#231f20" size="2" face="Verdana">regardless of gender (<a href="#tab2">Table 2</a>). In the case of serum folic</font> <font COLOR="#231f20" size="2" face="Verdana">acid, deficiency is moderate in all groups older than 10 years</font> <font COLOR="#231f20" size="2" face="Verdana">of age of both sexes. In children, values registered were above</font> <font COLOR="#231f20" size="2" face="Verdana">the cutoff point of 6 ng/mL, except for girls between 1 and 3</font> <font COLOR="#231f20" size="2" face="Verdana">years old, with a mean concentration of 4.51 ng/mL. The differences</font> <font COLOR="#231f20" size="2" face="Verdana">in all biochemical parameters studied, were not different</font> <font COLOR="#231f20" size="2" face="Verdana">statistically, between age and gender groups.</font></p>     <p ALIGN="center"><a name="tab2"><img border="0" src="/img/fbpe/alan/v58n1/art02tab2.jpg" width="494" height="562"></a></p>     
<p ALIGN="justify"><font COLOR="#231f20" size="2" face="Verdana">The prevalence of anemia and deficiencies of iron, folic acid</font> <font COLOR="#231f20" size="2" face="Verdana">and vitamin B12 by age and gender is shown in <a href="#tab3"> Table 3.</a> The</font> <font COLOR="#231f20" size="2" face="Verdana">highest prevalence of anemia was found in infants of both sexes,</font> <font COLOR="#231f20" size="2" face="Verdana">reaching 100%. Anemia affected the whole group studied, but</font> <font COLOR="#231f20" size="2" face="Verdana">was especially high in females of all ages, including women</font> <font COLOR="#231f20" size="2" face="Verdana">older than 40 years, with a prevalence of 80%. The prevalence</font> <font COLOR="#231f20" size="2" face="Verdana">of iron deficiency was also higher in females, affecting all ages</font> <font COLOR="#231f20" size="2" face="Verdana">studied. In males, iron deficiency was less prevalent than in</font> <font COLOR="#231f20" size="2" face="Verdana">women, and was higher in children below 3 years of age. Regarding</font> <font COLOR="#231f20" size="2" face="Verdana">folic acid and vitamin B</font><font face="Verdana" size="2" color="#231F20"><sub>12</sub></font> <font COLOR="#231f20" size="2" face="Verdana"> deficiencies, the highest</font> <font COLOR="#231f20" size="2" face="Verdana">prevalence was found in males for both nutrients. The prevalence</font> <font COLOR="#231f20" size="2" face="Verdana">of folic acid deficiency was high and affected all age</font> <font COLOR="#231f20" size="2" face="Verdana">groups, while vitamin B</font><font face="Verdana" size="2" color="#231F20"><sub>12</sub></font> <font COLOR="#231f20" size="2" face="Verdana"> deficiency was lower and less homogeneous</font> <font COLOR="#231f20" size="2" face="Verdana">in distribution, showing no cases of deficiency in women</font> <font COLOR="#231f20" size="2" face="Verdana">older than 40 years of age, probably due to a small sample size</font> <font COLOR="#231f20" size="2" face="Verdana">(n=52).</font></p>     <p ALIGN="center"><font color="#231f20" size="2" face="Verdana"><b><a name="tab3">tabla 3</a>. </b></font><font color="#231f20" size="2" face="Verdana">Prevalence of anemia and definciencies of irons, folic acid and vitam B</font><font face="Verdana" size="2" color="#231F20"><sub>12</sub> and prevalence of combinaned anemia + iron defency or anemia + iron deficiency + filic acid deficiency+ in the Piaro community of Betania del Topocho, Amazon State, Venezuela. Distribution by age and gender.</font></p>     <div align="center">       <center>   <table border="1" width="580">     <tr>       <td width="81" align="center">             <p align="justify"><font face="Verdana" size="2">Gender         and age         (years)</font></p>       </td>       <td width="54" align="center">             <p align="justify"><font face="Verdana" size="2">&nbsp;Anemia</font></td>       <td width="71" align="center">             ]]></body>
<body><![CDATA[<p align="justify"><font face="Verdana" size="2">&nbsp;Iron Deficiency</font></p>       </td>       <td width="76" align="center">             <p align="justify"><font face="Verdana" size="2">&nbsp;Folic         Acid &nbsp;Deficiency</font></p>       </td>       <td width="70" align="center">             <p align="justify"><font face="Verdana" size="2">&nbsp;Vit B<sub>12</sub>         Deficiency</font></p>       </td>       <td width="101" align="center">             <p align="justify"><font face="Verdana" size="2">Anemia         + Iron Deficiency</font></p>       </td>       <td width="81" align="center">             <p align="justify"><font face="Verdana" size="2">Anemia + Folic Acid Deficiency</font></p>       </td>       <td width="114" align="center">             <p align="justify"><font face="Verdana" size="2">Anamia + Iron Deficiency         +Acid Folic Deficiency</font></p>       </td>     </tr>     <tr>       <td colspan="8" width="690" align="center">             <p ALIGN="center"><font face="Verdana" size="2">Prevalence(%)</font></td>     </tr>     <tr>       <td width="648" colspan="8" align="center">             <p ALIGN="center"><font face="Verdana" size="2">FEMALE</font></p>       </td>     </tr>     <tr>       <td width="81" align="center">             <p ALIGN="justify"><font face="Verdana" size="2">1-3</font></p>       </td>       <td width="54" align="center">             <p ALIGN="justify"><font face="Verdana" size="2">100</font></p>       </td>       <td width="71" align="center">             ]]></body>
<body><![CDATA[<p ALIGN="justify"><font face="Verdana" size="2">56</font></p>       </td>       <td width="76" align="center">             <p ALIGN="justify"><font face="Verdana" size="2">75</font></p>       </td>       <td width="70" align="center">             <p ALIGN="justify"><font face="Verdana" size="2">0</font></p>       </td>       <td width="101" align="center">             <p ALIGN="justify"><font face="Verdana" size="2">56</font></p>       </td>       <td width="81" align="center">             <p ALIGN="justify"><font face="Verdana" size="2">75</font></p>       </td>       <td width="114" align="center">             <p ALIGN="justify"><font face="Verdana" size="2">60</font></p>       </td>     </tr>     <tr>       <td width="81" align="center">             <p ALIGN="justify"><font face="Verdana" size="2">4-10</font></p>       </td>       <td width="54" align="center">             <p ALIGN="justify"><font face="Verdana" size="2">100</font></p>       </td>       <td width="71" align="center">             <p ALIGN="justify"><font face="Verdana" size="2">31</font></p>       </td>       <td width="76" align="center">             <p ALIGN="justify"><font face="Verdana" size="2">50</font></p>       </td>       <td width="70" align="center">             ]]></body>
<body><![CDATA[<p ALIGN="justify"><font face="Verdana" size="2">10</font></p>       </td>       <td width="101" align="center">             <p ALIGN="justify"><font face="Verdana" size="2">29</font></p>       </td>       <td width="81" align="center">             <p ALIGN="justify"><font face="Verdana" size="2">60</font></p>       </td>       <td width="114" align="center">             <p ALIGN="justify"><font face="Verdana" size="2">22</font></p>       </td>     </tr>     <tr>       <td width="81" align="center">             <p ALIGN="justify"><font face="Verdana" size="2">11-20</font></p>       </td>       <td width="54" align="center">             <p ALIGN="justify"><font face="Verdana" size="2">90</font></p>       </td>       <td width="71" align="center">             <p ALIGN="justify"><font face="Verdana" size="2">55</font></p>       </td>       <td width="76" align="center">             <p ALIGN="justify"><font face="Verdana" size="2">90</font></p>       </td>       <td width="70" align="center">             <p ALIGN="justify"><font face="Verdana" size="2">20</font></p>       </td>       <td width="101" align="center">             <p ALIGN="justify"><font face="Verdana" size="2">50</font></p>       </td>       <td width="81" align="center">             ]]></body>
<body><![CDATA[<p ALIGN="justify"><font face="Verdana" size="2">60</font></p>       </td>       <td width="114" align="center">             <p ALIGN="justify"><font face="Verdana" size="2">50</font></p>       </td>     </tr>     <tr>       <td width="81" align="center">             <p ALIGN="justify"><font face="Verdana" size="2">21-40</font></p>       </td>       <td width="54" align="center">             <p ALIGN="justify"><font face="Verdana" size="2">94</font></p>       </td>       <td width="71" align="center">             <p ALIGN="justify"><font face="Verdana" size="2">41</font></p>       </td>       <td width="76" align="center">             <p ALIGN="justify"><font face="Verdana" size="2">80</font></p>       </td>       <td width="70" align="center">             <p ALIGN="justify"><font face="Verdana" size="2">5</font></p>       </td>       <td width="101" align="center">             <p ALIGN="justify"><font face="Verdana" size="2">41</font></p>       </td>       <td width="81" align="center">             <p ALIGN="justify"><font face="Verdana" size="2">75</font></p>       </td>       <td width="114" align="center">             <p ALIGN="justify"><font face="Verdana" size="2">46</font></p>       </td>     </tr>     <tr>       <td width="81" align="center">             ]]></body>
<body><![CDATA[<p ALIGN="justify"><font face="Verdana" size="2">41-+</font></p>       </td>       <td width="54" align="center">             <p ALIGN="justify"><font face="Verdana" size="2">80</font></p>       </td>       <td width="71" align="center">             <p ALIGN="justify"><font face="Verdana" size="2">33</font></p>       </td>       <td width="76" align="center">             <p ALIGN="justify"><font face="Verdana" size="2">38</font></p>       </td>       <td width="70" align="center">             <p ALIGN="justify"><font face="Verdana" size="2">0</font></p>       </td>       <td width="101" align="center">             <p ALIGN="justify"><font face="Verdana" size="2">33</font></p>       </td>       <td width="81" align="center">             <p ALIGN="justify"><font face="Verdana" size="2">38</font></p>       </td>       <td width="114" align="center">             <p ALIGN="justify"><font face="Verdana" size="2">20</font></p>       </td>     </tr>     <tr>       <td width="81" align="center">             <p ALIGN="justify"><font face="Verdana" size="2">TOTAL</font></p>       </td>       <td width="54" align="center">             <p ALIGN="justify"><font face="Verdana" size="2">93.45</font></p>       </td>       <td width="71" align="center">             ]]></body>
<body><![CDATA[<p ALIGN="justify"><font face="Verdana" size="2">43.2</font></p>       </td>       <td width="76" align="center">             <p ALIGN="justify"><font face="Verdana" size="2">66.6</font></p>       </td>       <td width="70" align="center">             <p ALIGN="justify"><font face="Verdana" size="2">7.0</font></p>       </td>       <td width="101" align="center">             <p ALIGN="justify"><font face="Verdana" size="2">41.8</font></p>       </td>       <td width="81" align="center">             <p ALIGN="justify"><font face="Verdana" size="2">61.6</font></p>       </td>       <td width="114" align="center">             <p ALIGN="justify"><font face="Verdana" size="2">39.60</font></p>       </td>     </tr>   </center>   <tr>     <td width="648" align="center" colspan="8">           <p ALIGN="center"><font face="Verdana" size="2">MALE</font></td>   </tr>       <center>   <tr>     <td width="81" align="center">           <p ALIGN="justify"><font face="Verdana" size="2">1-3</font></p>     </td>     <td width="54" align="center">           <p ALIGN="justify"><font face="Verdana" size="2">100</font></p>     </td>     <td width="71" align="center">           ]]></body>
<body><![CDATA[<p ALIGN="justify"><font face="Verdana" size="2">50</font></p>     </td>     <td width="76" align="center">           <p ALIGN="justify"><font face="Verdana" size="2">75</font></p>     </td>     <td width="70" align="center">           <p ALIGN="justify"><font face="Verdana" size="2">25</font></p>     </td>     <td width="101" align="center">           <p ALIGN="justify"><font face="Verdana" size="2">50</font></p>     </td>     <td width="81" align="center">           <p ALIGN="justify"><font face="Verdana" size="2">25</font></p>     </td>     <td width="114" align="center">           <p ALIGN="justify"><font face="Verdana" size="2">0</font></p>     </td>   </tr>   <tr>     <td width="81" align="center">           <p ALIGN="justify"><font face="Verdana" size="2">4-10</font></p>     </td>     <td width="54" align="center">           <p ALIGN="justify"><font face="Verdana" size="2">91</font></p>     </td>     <td width="71" align="center">           <p ALIGN="justify"><font face="Verdana" size="2">36</font></p>     </td>     <td width="76" align="center">           <p ALIGN="justify"><font face="Verdana" size="2">50</font></p>     </td>     <td width="70" align="center">           ]]></body>
<body><![CDATA[<p ALIGN="justify"><font face="Verdana" size="2">0</font></p>     </td>     <td width="101" align="center">           <p ALIGN="justify"><font face="Verdana" size="2">35</font></p>     </td>     <td width="81" align="center">           <p ALIGN="justify"><font face="Verdana" size="2">50</font></p>     </td>     <td width="114" align="center">           <p ALIGN="justify"><font face="Verdana" size="2">13</font></p>     </td>   </tr>   <tr>     <td width="81" align="center">           <p ALIGN="justify"><font face="Verdana" size="2">11-20</font></p>     </td>     <td width="54" align="center">           <p ALIGN="justify"><font face="Verdana" size="2">83</font></p>     </td>     <td width="71" align="center">           <p ALIGN="justify"><font face="Verdana" size="2">25</font></p>     </td>     <td width="76" align="center">           <p ALIGN="justify"><font face="Verdana" size="2">88</font></p>     </td>     <td width="70" align="center">           <p ALIGN="justify"><font face="Verdana" size="2">22</font></p>     </td>     <td width="101" align="center">           <p ALIGN="justify"><font face="Verdana" size="2">17</font></p>     </td>     <td width="81" align="center">           ]]></body>
<body><![CDATA[<p ALIGN="justify"><font face="Verdana" size="2">75</font></p>     </td>     <td width="114" align="center">           <p ALIGN="justify"><font face="Verdana" size="2">50</font></p>     </td>   </tr>   <tr>     <td width="81" align="center">           <p ALIGN="justify"><font face="Verdana" size="2">21-40</font></p>     </td>     <td width="54" align="center">           <p ALIGN="justify"><font face="Verdana" size="2">65</font></p>     </td>     <td width="71" align="center">           <p ALIGN="justify"><font face="Verdana" size="2">26</font></p>     </td>     <td width="76" align="center">           <p ALIGN="justify"><font face="Verdana" size="2">100</font></p>     </td>     <td width="70" align="center">           <p ALIGN="justify"><font face="Verdana" size="2">9</font></p>     </td>     <td width="101" align="center">           <p ALIGN="justify"><font face="Verdana" size="2">25</font></p>     </td>     <td width="81" align="center">           <p ALIGN="justify"><font face="Verdana" size="2">73</font></p>     </td>     <td width="114" align="center">           <p ALIGN="justify"><font face="Verdana" size="2">60</font></p>     </td>   </tr>   <tr>     <td width="81" align="center">           ]]></body>
<body><![CDATA[<p ALIGN="justify"><font face="Verdana" size="2">41-+</font></p>     </td>     <td width="54" align="center">           <p ALIGN="justify"><font face="Verdana" size="2">95</font></p>     </td>     <td width="71" align="center">           <p ALIGN="justify"><font face="Verdana" size="2">18</font></p>     </td>     <td width="76" align="center">           <p ALIGN="justify"><font face="Verdana" size="2">57</font></p>     </td>     <td width="70" align="center">           <p ALIGN="justify"><font face="Verdana" size="2">33</font></p>     </td>     <td width="101" align="center">           <p ALIGN="justify"><font face="Verdana" size="2">20</font></p>     </td>     <td width="81" align="center">           <p ALIGN="justify"><font face="Verdana" size="2">43</font></p>     </td>     <td width="114" align="center">           <p ALIGN="justify"><font face="Verdana" size="2">50</font></p>     </td>   </tr>   <tr>     <td width="81" align="center">           <p ALIGN="justify"><font face="Verdana" size="2">TOTAL</font></p>     </td>     <td width="54" align="center">           <p ALIGN="justify"><font face="Verdana" size="2">85.80</font></p>     </td>     <td width="71" align="center">           ]]></body>
<body><![CDATA[<p ALIGN="justify"><font face="Verdana" size="2">31.08</font></p>     </td>     <td width="76" align="center">           <p ALIGN="justify"><font face="Verdana" size="2">74.0</font></p>     </td>     <td width="70" align="center">           <p ALIGN="justify"><font face="Verdana" size="2">17.8</font></p>     </td>     <td width="101" align="center">           <p ALIGN="justify"><font face="Verdana" size="2">29.4</font></p>     </td>     <td width="81" align="center">           <p ALIGN="justify"><font face="Verdana" size="2">53.2</font></p>     </td>     <td width="114" align="center">           <p ALIGN="justify"><font face="Verdana" size="2">36.80</font></p>     </td>   </tr>   <tr>     <td width="81" align="center">           <p ALIGN="justify"><font face="Verdana" size="2">TOTAL</font></p>     </td>     <td width="54" align="center">           <p ALIGN="justify"><font face="Verdana" size="2">89.63</font></p>     </td>     <td width="71" align="center">           <p ALIGN="justify"><font face="Verdana" size="2">37.10</font></p>     </td>     <td width="76" align="center">           <p ALIGN="justify"><font face="Verdana" size="2">70.3</font></p>     </td>     <td width="70" align="center">           ]]></body>
<body><![CDATA[<p ALIGN="justify"><font face="Verdana" size="2">12.4</font></p>     </td>     <td width="101" align="center">           <p ALIGN="justify"><font face="Verdana" size="2">35.6</font></p>     </td>     <td width="81" align="center">           <p ALIGN="justify"><font face="Verdana" size="2">57.4</font></p>     </td>     <td width="114" align="center">           <p ALIGN="justify"><font face="Verdana" size="2">38.2</font></p>     </td>   </tr>   </table>   </center> </div>     <p ALIGN="justify"><font COLOR="#231f20" size="2" face="Verdana">The prevalence of iron deficiency increases to 92% when</font> <font COLOR="#231f20" size="2" face="Verdana">the cutoff point for iron deficiency is set in 30 &#956;g/L. In this</font> <font COLOR="#231f20" size="2" face="Verdana">scenario, the prevalence of combined anemia and iron deficiency</font> <font COLOR="#231f20" size="2" face="Verdana">reached 93.3 % indicating that all anemia cases presented</font> <font COLOR="#231f20" size="2" face="Verdana">iron deficiency. For the combination of anemia, iron</font> <font COLOR="#231f20" size="2" face="Verdana">and folic acid deficiencies, the prevalence was 58.1%.</font></p>     <p ALIGN="justify"><font COLOR="#231f20" size="2" face="Verdana">When the sample was analyzed as a whole, (<a href="#fig1">Figure 1</a>), there</font> <font COLOR="#231f20" size="2" face="Verdana">was high prevalence of anemia and folic acid deficiency (89.6</font> <font COLOR="#231f20" size="2" face="Verdana">and 70.3%, respectively) with a moderate and atypical prevalence</font> <font COLOR="#231f20" size="2" face="Verdana">of iron deficiency (37.1%), and a low prevalence of vitamin</font> <font COLOR="#231f20" size="2" face="Verdana">B</font><font face="Verdana" size="2" color="#231F20"><sub>12 </sub></font> <font COLOR="#231f20" size="2" face="Verdana"> deficiency (12.4%). When a cutoff point of 30 was</font> <font COLOR="#231f20" size="2" face="Verdana">used for ferritin concentration, iron deficiency reached 91.6%</font> <font COLOR="#231f20" size="2" face="Verdana">of prevalence. It was also found that 86% of the individuals</font> <font COLOR="#231f20" size="2" face="Verdana">with molecular diagnosis of malaria, presented anemia.</font></p>     <p ALIGN="center"><a name="fig1"><img border="0" src="/img/fbpe/alan/v58n1/art02fig1.jpg" width="498" height="594"></a></p> <b>     
<p ALIGN="justify"><font COLOR="#231f20" size="2" face="Verdana">DISCUSSION</font></p> </b>     <p ALIGN="justify"><font COLOR="#231f20" size="2" face="Verdana">The study performed in this community showed a high</font> <font COLOR="#231f20" size="2" face="Verdana">prevalence of anemia and folic acid deficiency, that is evident</font> <font COLOR="#231f20" size="2" face="Verdana">not only by individual data but also by the mean levels obtained</font> <font COLOR="#231f20" size="2" face="Verdana">for the entire population. These low general mean values,</font> <font COLOR="#231f20" size="2" face="Verdana">indicate that the majority of the population studied is affected</font> <font COLOR="#231f20" size="2" face="Verdana">by these deficiencies, which requires an immediate and</font> <font COLOR="#231f20" size="2" face="Verdana">massive nutritional intervention.</font> <font COLOR="#231f20" size="2" face="Verdana">The sample studied included individuals from all age</font> <font COLOR="#231f20" size="2" face="Verdana">groups, and although the individuals voluntarily included themselves</font> <font COLOR="#231f20" size="2" face="Verdana">in the study, they represented almost 50% of the community</font> <font COLOR="#231f20" size="2" face="Verdana">and had the same age distribution found for the indigenous</font> <font COLOR="#231f20" size="2" face="Verdana">community of the whole Amazonas State. Gender distribution</font> <font COLOR="#231f20" size="2" face="Verdana">however, showed and increase percentage of females</font> <font COLOR="#231f20" size="2" face="Verdana">compared to the state population, probably due to the interest</font> <font COLOR="#231f20" size="2" face="Verdana">of mothers to obtain malaria diagnoses for their children.</font></p>     <p ALIGN="justify"><font COLOR="#231f20" size="2" face="Verdana">Prevalence of anemia reached values close to 90% for the</font> <font COLOR="#231f20" size="2" face="Verdana">total population and 100% for boys and girls with less than 3</font> <font COLOR="#231f20" size="2" face="Verdana">years of age. For the last few years, data obtained in Venezuela</font> <font COLOR="#231f20" size="2" face="Verdana">and in other underdeveloped countries, seem to indicate</font> <font COLOR="#231f20" size="2" face="Verdana">that other factors, besides iron deficiency, could have a role in</font> <font COLOR="#231f20" size="2" face="Verdana">the reported prevalence of anemia (22). Results from this work</font> <font COLOR="#231f20" size="2" face="Verdana">show that anemia due to iron deficiency account only for 35.6%</font> <font COLOR="#231f20" size="2" face="Verdana">of the cases, with a total prevalence of anemia of 89.6%, These</font> <font COLOR="#231f20" size="2" face="Verdana">results were obtained with the cutoff points for normal populations,</font> <font COLOR="#231f20" size="2" face="Verdana">and it can be noticed that all iron deficient cases studied</font> <font COLOR="#231f20" size="2" face="Verdana">were anemic, although it is clear from the high prevalence</font> <font COLOR="#231f20" size="2" face="Verdana">of anemia registered, that there were other causes of anemia.</font></p>     ]]></body>
<body><![CDATA[<p ALIGN="justify"><font COLOR="#231f20" size="2" face="Verdana">The cases of anemia that could be due to folic acid deficiency</font> <font COLOR="#231f20" size="2" face="Verdana">reach 26.7%, using the cutoff of &lt;3ng/ml for severe folic</font> <font COLOR="#231f20" size="2" face="Verdana">acid levels, or 57.4% with the cutoff of 6 ng/mL, for severe and</font> <font COLOR="#231f20" size="2" face="Verdana">moderate folic acid deficiency. With the first cutoff point, there</font> <font COLOR="#231f20" size="2" face="Verdana">is a 27.3% of anemia cases (to complete the total prevalence of</font> <font COLOR="#231f20" size="2" face="Verdana">89.6%) due to other causes, different for iron and folic acid</font> <font COLOR="#231f20" size="2" face="Verdana">deficiencies, and could have an non-nutritional origin, while</font> <font COLOR="#231f20" size="2" face="Verdana">the more broad cutoff point, could explain the rest of the cases</font> <font COLOR="#231f20" size="2" face="Verdana">not produced by iron deficiency, although an important number</font> <font COLOR="#231f20" size="2" face="Verdana">of cases (38.2% of the anemic population) presented combined</font> <font COLOR="#231f20" size="2" face="Verdana">iron and folic acid deficiencies.</font> <font COLOR="#231f20" size="2" face="Verdana">One problem to clarify the origin of the anemia is that</font> <font COLOR="#231f20" size="2" face="Verdana">ferritin is an acute phase protein, that is elevated in case of</font> <font COLOR="#231f20" size="2" face="Verdana">infections, and in this population the proportion of anemia</font></p>     <p ALIGN="justify"><font COLOR="#231f20" size="2" face="Verdana">produced by iron deficiency could be underestimated, since</font> <font COLOR="#231f20" size="2" face="Verdana">the diagnosis of iron deficiency was based only on ferritin</font> <font COLOR="#231f20" size="2" face="Verdana">concentration.</font> <font COLOR="#231f20" size="2" face="Verdana">The fluctuating and relatively moderate prevalence of iron</font> <font COLOR="#231f20" size="2" face="Verdana">deficiency by age and gender, was probably due to the fact</font> <font COLOR="#231f20" size="2" face="Verdana">that ferritin was not only reflecting iron stores, but also the</font> <font COLOR="#231f20" size="2" face="Verdana">presence of infections in those individuals. It is possible that</font> <font COLOR="#231f20" size="2" face="Verdana">the difference found in this study between prevalence of anemia</font> <font COLOR="#231f20" size="2" face="Verdana">and iron deficiency was due to incidence of infections,</font> <font COLOR="#231f20" size="2" face="Verdana">especially malaria, with a direct effect not only on erythrocytes,</font> <font COLOR="#231f20" size="2" face="Verdana">but on serum ferritin concentration. As mentioned before,</font> <font COLOR="#231f20" size="2" face="Verdana">53% of the population studied presented malaria infection</font> <font COLOR="#231f20" size="2" face="Verdana">and from this group, almost 90% was anemic. As a matter</font> <font COLOR="#231f20" size="2" face="Verdana">of fact, when the cutoff point for ferritin concentration</font> <font COLOR="#231f20" size="2" face="Verdana">was adjusted 30 &#956;g/L, the prevalence of iron deficiency increased</font> <font COLOR="#231f20" size="2" face="Verdana">to 92% of the cases studied, and could explain all the</font> <font COLOR="#231f20" size="2" face="Verdana">cases of anemia reported. Also, the prevalence of combined</font> <font COLOR="#231f20" size="2" face="Verdana">anemia, iron and folic acid deficiencies increased to 58% indicating</font> <font COLOR="#231f20" size="2" face="Verdana">that combined or multiple deficiency of nutrients is</font> <font COLOR="#231f20" size="2" face="Verdana">the main problem in this population, along with infections.</font></p>     <p ALIGN="justify"><font COLOR="#231f20" size="2" face="Verdana">It is interesting to highlight that the treatment for these</font> <font COLOR="#231f20" size="2" face="Verdana">populations is multifactorial: a treatment for the infectious</font> <font COLOR="#231f20" size="2" face="Verdana">process in a first phase and then begin the adequate feeding</font> <font COLOR="#231f20" size="2" face="Verdana">or the introduction of specific nutrients that are in deficit. The</font> <font COLOR="#231f20" size="2" face="Verdana">proper improvement in quality of life, education and access</font> <font COLOR="#231f20" size="2" face="Verdana">to services are also necessary.</font></p>     <p ALIGN="justify"><font COLOR="#231f20" size="2" face="Verdana">The scarce reports on nutritional status in Indigenous populations</font> <font COLOR="#231f20" size="2" face="Verdana">in Venezuela, indicate that there in an important nutritional</font> <font COLOR="#231f20" size="2" face="Verdana">problem. A report on 97 preschool and scholar Piaroa</font> <font COLOR="#231f20" size="2" face="Verdana">children living in 9 Communities of Amazonas State, showed</font> <font COLOR="#231f20" size="2" face="Verdana">a prevalence of anemia of 80% and 48% in boys and girls,</font> <font COLOR="#231f20" size="2" face="Verdana">respectively (23). The study of a Yucpa Indigenous community</font> <font COLOR="#231f20" size="2" face="Verdana">in a western region of Venezuela (24), reported that the</font> <font COLOR="#231f20" size="2" face="Verdana">prevalence of anemia was 71% and in half of the cases, there</font> <font COLOR="#231f20" size="2" face="Verdana">was no iron, folic acid or vitamin B12 deficiencies. The preva-prevalence</font> <font COLOR="#231f20" size="2" face="Verdana">found in the present study, and folate deficiency was</font> <font COLOR="#231f20" size="2" face="Verdana">12.9%. The authors explain the presence of anemia without</font> <font COLOR="#231f20" size="2" face="Verdana">iron deficiency, to the incidence of infectious diseases such as</font> <font COLOR="#231f20" size="2" face="Verdana">hepatitis, parasitic, skin and gastrointestinal tract infections.</font> <font COLOR="#231f20" size="2" face="Verdana">In another study from the same authors (25) in 2 communities</font> <font COLOR="#231f20" size="2" face="Verdana">of Bari indians, they report a high prevalence of anemia</font> <font COLOR="#231f20" size="2" face="Verdana">not due to iron deficiency, attributing the results to nutritional</font> <font COLOR="#231f20" size="2" face="Verdana">deficiencies and high incidence of infections.</font></p>     <p ALIGN="justify"><font COLOR="#231f20" size="2" face="Verdana">The high prevalence of malaria, anemia, iron and folic acid</font> <font COLOR="#231f20" size="2" face="Verdana">deficiency indicate a health and nutrition problem in this population,</font> <font COLOR="#231f20" size="2" face="Verdana">that should be properly and urgently addressed. Anemia</font> <font COLOR="#231f20" size="2" face="Verdana">incidence could be due to nutritional deficiencies of iron</font> <font COLOR="#231f20" size="2" face="Verdana">and folic acid, as well as to malaria. Anemia cases due to iron</font> <font COLOR="#231f20" size="2" face="Verdana">deficiency could be underestimated, since the biochemical</font> <font COLOR="#231f20" size="2" face="Verdana">indicator used to measure iron reserves (serum ferritin) is also</font> <font COLOR="#231f20" size="2" face="Verdana">an acute phase reactant that increases in cases of infection,</font> <font COLOR="#231f20" size="2" face="Verdana">although, as shown in this work, changing the cutoff point for</font> <font COLOR="#231f20" size="2" face="Verdana">this protein concentration, could help in obtaining a general</font> <font COLOR="#231f20" size="2" face="Verdana">idea of the magnitude of the problem.</font></p> <b>     <p ALIGN="justify"><font COLOR="#231f20" size="2" face="Verdana">ACKNOWLEDGMENT</font></p> </b>     <p ALIGN="justify"><font COLOR="#231f20" size="2" face="Verdana">Authors are grateful to the Community of Betania del</font> <font COLOR="#231f20" size="2" face="Verdana">Topocho from Amazonas State, Venezuela for their participation</font> <font COLOR="#231f20" size="2" face="Verdana">in the study, to Licentiate Irma Rodríguez and to the</font> <font COLOR="#231f20" size="2" face="Verdana">Centro Amazónico de Investigación y Control de</font> <font COLOR="#231f20" size="2" face="Verdana">Enfermedades Tropicales (CAICET) from Amazonas State,</font> <font COLOR="#231f20" size="2" face="Verdana">for their collaboration in sample collection and processing.</font> <font COLOR="#231f20" size="2" face="Verdana">We also thank Venezuelan Air Force for transportation during</font> <font COLOR="#231f20" size="2" face="Verdana">the study.</font></p> <b>     <p ALIGN="justify"><font COLOR="#231f20" size="2" face="Verdana">REFERENCES</font></p> </b>     <!-- ref --><p ALIGN="justify"><font COLOR="#231f20" size="2" face="Verdana">1. International Anemia Consultative Group (INACG). Guidelines</font> <font COLOR="#231f20" size="2" face="Verdana">for the eradication of iron deficiency anaemia. A report of the</font> <font COLOR="#231f20" size="2" face="Verdana">International Nutritional Anaemia Consultative Group. Washington,</font> <font COLOR="#231f20" size="2" face="Verdana">DC: The Nutrition Foundation. 1977.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=484170&pid=S0004-0622200800010000200001&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p ALIGN="justify"><font COLOR="#231f20" size="2" face="Verdana">2. WHO-UNICEF. Indicators and strategies for iron deficiency</font> <font COLOR="#231f20" size="2" face="Verdana">and anaemia programs. World Health Organization Technical</font> <font COLOR="#231f20" size="2" face="Verdana">Report. September 1993.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=484171&pid=S0004-0622200800010000200002&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p ALIGN="justify"><font COLOR="#231f20" size="2" face="Verdana">3. ILSI-OPS. International Life Science Institute (ILSI), Pan</font> <font COLOR="#231f20" size="2" face="Verdana">American Health Organization (OPS). Ácido fólico y Vitamina</font> <font COLOR="#231f20" size="2" face="Verdana">B12. In: Conocimientos actuales sobre nutrición. Seventh Edition.</font> <font COLOR="#231f20" size="2" face="Verdana">Ziegler y Filer Eds. Washington DC, USA. p 235-263.</font> <font COLOR="#231f20" size="2" face="Verdana">1997.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=484172&pid=S0004-0622200800010000200003&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p ALIGN="justify"><font COLOR="#231f20" size="2" face="Verdana">4. Machlin L, Hüni J. Vitamin A. Folic Acid. Vitamins, basics.</font> <font COLOR="#231f20" size="2" face="Verdana">Hoffmann-La Roche LTD. Basel Switzerland. pp 37-40, 49-</font> <font COLOR="#231f20" size="2" face="Verdana">51. 1994.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=484173&pid=S0004-0622200800010000200004&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p ALIGN="justify"><font COLOR="#231f20" size="2" face="Verdana">5. Giovanucci E, Stampfer M. Folate, methionine and alcohol</font> <font COLOR="#231f20" size="2" face="Verdana">intake and the risk of colorectal adenoma. J Nat Cancer Inst.</font> <font COLOR="#231f20" size="2" face="Verdana">1993; 87: 895-904.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=484174&pid=S0004-0622200800010000200005&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p ALIGN="justify"><font COLOR="#231f20" size="2" face="Verdana">6. Woon Choi S, Friso S, Dolnikowski G, Bagley P, Edmonson,</font> <font COLOR="#231f20" size="2" face="Verdana">A, Smith D, Mason J. Biochemical and molecular aberrations</font> <font COLOR="#231f20" size="2" face="Verdana">in the rat colon due to folate depletion are age-specific. J Nutr.</font> <font COLOR="#231f20" size="2" face="Verdana">2003; 133: 1206-1212.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=484175&pid=S0004-0622200800010000200006&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p ALIGN="justify"><font COLOR="#231f20" size="2" face="Verdana">7. Woon Choi S, Mason J. Folate and carcinogenesis: an integrated</font> <font COLOR="#231f20" size="2" face="Verdana">scheme. J Nutr. 2000; 130: 129-132.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=484176&pid=S0004-0622200800010000200007&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p ALIGN="justify"><font COLOR="#231f20" size="2" face="Verdana">8. Czeizel A. Folic acid in the prevention of neural tube defects. J</font> <font COLOR="#231f20" size="2" face="Verdana">Ped Gastroent. 1995; 2: 4-16.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=484177&pid=S0004-0622200800010000200008&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p ALIGN="justify"><font COLOR="#231f20" size="2" face="Verdana">9. Medical Research Council. Prevention of neural tube defects:</font> <font COLOR="#231f20" size="2" face="Verdana">results of the Medial Research Council Vitamin Study. Lancet</font> <font COLOR="#231f20" size="2" face="Verdana">1991; 338: 131-137.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=484178&pid=S0004-0622200800010000200009&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p ALIGN="justify"><font COLOR="#231f20" size="2" face="Verdana">10. Brattström L, Wilcken D. Homocysteine and cardiovascular</font> <font COLOR="#231f20" size="2" face="Verdana">disease: cause or effect? Am J Clin Nutr. 2000; 72: 315- 323.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=484179&pid=S0004-0622200800010000200010&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p ALIGN="justify"><font COLOR="#231f20" size="2" face="Verdana">11. McKinley M, McNulty H, McPartlin J, Strain J, Pentieva K,</font> <font COLOR="#231f20" size="2" face="Verdana">Ward M, Weir D, Scott J. Low-dose vitamin B6 effectively lowers</font> <font COLOR="#231f20" size="2" face="Verdana">fasting plasma homocysteine in healthy elderly persons who</font> <font COLOR="#231f20" size="2" face="Verdana">are folate and riboflavin replete. Am J Clin Nutr. 2001; 73:</font> <font COLOR="#231f20" size="2" face="Verdana">759-764.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=484180&pid=S0004-0622200800010000200011&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p ALIGN="justify"><font COLOR="#231f20" size="2" face="Verdana">12. Stipanuk M. Folic acid, vitamin B</font><font face="Verdana" size="2" color="#231F20"><sub>12</sub></font><font COLOR="#231f20" size="2" face="Verdana"> and vitamin B6. In: Biochemical</font> <font COLOR="#231f20" size="2" face="Verdana">and physiological aspects of human nutrition. W.B</font> <font COLOR="#231f20" size="2" face="Verdana">Saunders Company. Philadelphia pp 483-518. 2000.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=484181&pid=S0004-0622200800010000200012&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p ALIGN="justify"><font COLOR="#231f20" size="2" face="Verdana">13. Hebert V. Staging vitamin B</font><font face="Verdana" size="2" color="#231F20"><sub>12 </sub></font><font COLOR="#231f20" size="2" face="Verdana"> status in vegetarians. Am J Clin</font> <font COLOR="#231f20" size="2" face="Verdana">Nutr. 1994; 59(Suppl): 1213S- 1222S.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=484182&pid=S0004-0622200800010000200013&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p ALIGN="justify"><font COLOR="#231f20" size="2" face="Verdana">14. Allen L. Vitamin B</font><font face="Verdana" size="2" color="#231F20"><sub>12</sub></font><font COLOR="#231f20" size="2" face="Verdana"> metabolism and status during pregnancy,</font> <font COLOR="#231f20" size="2" face="Verdana">lactation and infancy. Adv Exp Med Biol. 1994; 352: 173-</font> <font COLOR="#231f20" size="2" face="Verdana">186.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=484183&pid=S0004-0622200800010000200014&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p ALIGN="justify"><font COLOR="#231f20" size="2" face="Verdana">15. Rodríguez G. Ácido fólico y vitamina B</font><font face="Verdana" size="2" color="#231F20"><sub>12 </sub></font><font COLOR="#231f20" size="2" face="Verdana"> en la nutrición</font> <font COLOR="#231f20" size="2" face="Verdana">humana. Rev Cub Alim Nutr. 1998; 12(2):107-119.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=484184&pid=S0004-0622200800010000200015&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p ALIGN="justify"><font COLOR="#231f20" size="2" face="Verdana">16. Instituto Nacional de Estadística. Proyecciones del Censo 2001.</font> <font COLOR="#231f20" size="2" face="Verdana">http://www.ine.gov.ve. Information obtained in November</font> <font COLOR="#231f20" size="2" face="Verdana">2006, and January 2008.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=484185&pid=S0004-0622200800010000200016&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p ALIGN="justify"><font COLOR="#231f20" size="2" face="Verdana">17. World Press. Informe de una dinámica de grupo con la</font> <font COLOR="#231f20" size="2" face="Verdana">cooperativa Ärümechä en la comunidad piaroa de Betania del</font> <font COLOR="#231f20" size="2" face="Verdana">Topocho, Estado Amazonas. 2005. http://babilonia.</font> <font COLOR="#231f20" size="2" face="Verdana">thinkertothinker.com/. Consulted on December 2006 and January</font> <font COLOR="#231f20" size="2" face="Verdana">2008.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=484186&pid=S0004-0622200800010000200017&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p ALIGN="justify"><font COLOR="#231f20" size="2" face="Verdana">18. International Committee for Standardization in Hematology.</font> <font COLOR="#231f20" size="2" face="Verdana">Recommendation for measurement of serum iron in human</font> <font COLOR="#231f20" size="2" face="Verdana">blood. Brit J Haematol. 1978; 38:291-294.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=484187&pid=S0004-0622200800010000200018&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p ALIGN="justify"><font COLOR="#231f20" size="2" face="Verdana">19. International Committee for Standardization in Hematology.</font> <font COLOR="#231f20" size="2" face="Verdana">The measurement of total and saturated iron-binding capacity</font> <font COLOR="#231f20" size="2" face="Verdana">in serum. Brit J Haematol. 1978; 38: 281-290.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=484188&pid=S0004-0622200800010000200019&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p ALIGN="justify"><font COLOR="#231f20" size="2" face="Verdana">20. Flowers C, Kuizon M, Beard S, Skikne B; Covell A, Cook J.</font> <font COLOR="#231f20" size="2" face="Verdana">A serum ferritin assay for prevalence studies of iron deficiency.</font> <font COLOR="#231f20" size="2" face="Verdana">Am J Hematol. 1986; 23: 141-151.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=484189&pid=S0004-0622200800010000200020&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p ALIGN="justify"><font COLOR="#231f20" size="2" face="Verdana">21. DPC Diagnostic Product Corporation. Dualcount Solid Phase</font> <font COLOR="#231f20" size="2" face="Verdana">No Boil Assay for Vitamin B</font><font face="Verdana" size="2" color="#231F20"><sub>12 </sub></font> <font COLOR="#231f20" size="2" face="Verdana"> and Folic Acid. Brochure included</font> <font COLOR="#231f20" size="2" face="Verdana">with the kit. California USA. 1999.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=484190&pid=S0004-0622200800010000200021&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p ALIGN="justify"><font COLOR="#231f20" size="2" face="Verdana">22. Suárez T, Torrealba M, Villegas N, Osorio C, García-Casal MN.</font> <font COLOR="#231f20" size="2" face="Verdana">Deficiencias de hierro, ácido fólico y vitamina B</font><font face="Verdana" size="2" color="#231F20"><sub>12 </sub></font> <font COLOR="#231f20" size="2" face="Verdana"> en relación</font> <font COLOR="#231f20" size="2" face="Verdana">a anemia, en adolescentes de una zona con alta incidencia de</font> <font COLOR="#231f20" size="2" face="Verdana">malformaciones congénitas en Venezuela. Arch Latinoam Nutr.</font> <font COLOR="#231f20" size="2" face="Verdana">2005; 55 (2): 118-123.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=484191&pid=S0004-0622200800010000200022&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p ALIGN="justify"><font COLOR="#231f20" size="2" face="Verdana">23. Hidalgo G. Vitamina A, anemia y antropometría nutricional en</font> <font COLOR="#231f20" size="2" face="Verdana">pre-escolares y escolares Piaroa, Estado Amazonas. (Vitamin</font> <font COLOR="#231f20" size="2" face="Verdana">A, anemia and nutritional anthropometrics in Piaroa</font> <font COLOR="#231f20" size="2" face="Verdana">preschoolers and scholars, Amazonas State). Thesis for Master</font> <font COLOR="#231f20" size="2" face="Verdana">in Nutrition from Universidad Simón Bolívar. Caracas,</font> <font COLOR="#231f20" size="2" face="Verdana">Venezuela pp 61-66. 2002.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=484192&pid=S0004-0622200800010000200023&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p ALIGN="justify"><font COLOR="#231f20" size="2" face="Verdana">24. Diez-Ewald M, Torres-Guerra E, Leets I, Layrisse M, Vizcaíno</font> <font COLOR="#231f20" size="2" face="Verdana">G, Arteaga M. Anemia en poblaciones indígenas del Occidente</font> <font COLOR="#231f20" size="2" face="Verdana">Venezolano. Invest Clín. 1999; 40 (3): 191-202.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=484193&pid=S0004-0622200800010000200024&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p ALIGN="justify"><font COLOR="#231f20" size="2" face="Verdana">25. Diez-Ewald M, Torres-Guerra E, Leets I, Layrisse M, Vizcaíno</font> <font COLOR="#231f20" size="2" face="Verdana">G, Arteaga M. Prevalencia de anemia y deficiencias de hierro,</font> <font COLOR="#231f20" size="2" face="Verdana">ácido fólico y vitamina B</font><font face="Verdana" size="2" color="#231F20"><sub>12</sub></font> <font COLOR="#231f20" size="2" face="Verdana"> en 2 comunidades Bari al oeste de</font> <font COLOR="#231f20" size="2" face="Verdana">Venezuela. Invest Clín. 1997; 38 (4): 191-201.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=484194&pid=S0004-0622200800010000200025&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --> ]]></body>
<back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="book">
<collab>International Anemia Consultative Group</collab>
<source><![CDATA[Guidelines for the eradication of iron deficiency anaemia: A report of the International Nutritional Anaemia Consultative Group]]></source>
<year>1977</year>
<publisher-loc><![CDATA[Washington^eDC DC]]></publisher-loc>
<publisher-name><![CDATA[The Nutrition Foundation]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="book">
<collab>WHO-UNICEF</collab>
<source><![CDATA[Indicators and strategies for iron deficiency and anaemia programs]]></source>
<year>Sept</year>
<month>em</month>
<day>be</day>
<publisher-name><![CDATA[World Health Organization Technical Report.]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="">
<collab>ILSI-OPS. International Life Science Institute (ILSI), Pan American Health Organization (OPS)</collab>
<article-title xml:lang="es"><![CDATA[Ácido fólico y Vitamina B12]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ziegler]]></surname>
</name>
<name>
<surname><![CDATA[Filer]]></surname>
</name>
</person-group>
<source><![CDATA[Conocimientos actuales sobre nutrición]]></source>
<year>1997</year>
<edition>Seventh</edition>
<page-range>235-263</page-range><publisher-loc><![CDATA[Washington^eDC DC]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Machlin]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Hüni]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Vitamin A. Folic Acid: Vitamins, basics]]></source>
<year>1994</year>
<page-range>37-40, 49- 51</page-range><publisher-loc><![CDATA[Basel Switzerland ]]></publisher-loc>
<publisher-name><![CDATA[Hoffmann-La Roche LTD]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Giovanucci]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Stampfer]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Folate, methionine and alcohol intake and the risk of colorectal adenoma]]></article-title>
<source><![CDATA[J Nat Cancer Inst.]]></source>
<year>1993</year>
<volume>87</volume>
<page-range>895-904</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Woon]]></surname>
<given-names><![CDATA[Choi S]]></given-names>
</name>
<name>
<surname><![CDATA[Friso]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Dolnikowski]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Bagley]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Edmonson,]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Smith]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Mason]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Biochemical and molecular aberrations in the rat colon due to folate depletion are age-specific]]></article-title>
<source><![CDATA[J Nutr.]]></source>
<year>2003</year>
<volume>133</volume>
<page-range>1206-1212</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Woon Choi]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Mason]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Folate and carcinogenesis: an integrated scheme]]></article-title>
<source><![CDATA[J Nutr.]]></source>
<year>2000</year>
<volume>130</volume>
<page-range>129-132</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Czeizel]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Folic acid in the prevention of neural tube defects]]></article-title>
<source><![CDATA[J Ped Gastroent.]]></source>
<year>1995</year>
<volume>2</volume>
<page-range>4-16</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<collab>Medical Research Council</collab>
<article-title xml:lang="en"><![CDATA[Prevention of neural tube defects: results of the Medial Research Council Vitamin Study]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>1991</year>
<volume>338</volume>
<page-range>131-137</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Brattström]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Wilcken]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Homocysteine and cardiovascular disease: cause or effect?]]></article-title>
<source><![CDATA[Am J Clin Nutr.]]></source>
<year>2000</year>
<volume>72</volume>
<page-range>315- 323</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[McKinley]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[McNulty]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[McPartlin]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Strain]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Pentieva]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Ward]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Weir]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Scott]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Low-dose vitamin B6 effectively lowers fasting plasma homocysteine in healthy elderly persons who are folate and riboflavin replete]]></article-title>
<source><![CDATA[Am J Clin Nutr.]]></source>
<year>2001</year>
<volume>73</volume>
<page-range>759-764</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Stipanuk]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Folic acid, vitamin B12 and vitamin B6]]></article-title>
<source><![CDATA[Biochemical and physiological aspects of human nutrition]]></source>
<year>2000</year>
<page-range>483-518</page-range><publisher-loc><![CDATA[Philadelphia ]]></publisher-loc>
<publisher-name><![CDATA[W.B Saunders Company]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hebert]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Staging vitamin B12 status in vegetarians]]></article-title>
<source><![CDATA[Am J Clin Nutr.]]></source>
<year>1994</year>
<volume>59</volume>
<page-range>1213S- 1222S</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Allen]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Vitamin B12 metabolism and status during pregnancy, lactation and infancy]]></article-title>
<source><![CDATA[Adv Exp Med Biol.]]></source>
<year>1994</year>
<volume>352</volume>
<page-range>173- 186</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Ácido fólico y vitamina B12 en la nutrición humana]]></article-title>
<source><![CDATA[Rev Cub Alim Nutr.]]></source>
<year>1998</year>
<volume>12</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>107-119</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="">
<collab>Instituto Nacional de Estadística</collab>
<source><![CDATA[Proyecciones del Censo 2001]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="">
<collab>World Press</collab>
<source><![CDATA[Informe de una dinámica de grupo con la cooperativa Ärümechä en la comunidad piaroa de Betania del Topocho, Estado Amazonas]]></source>
<year>2005</year>
</nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<collab>International Committee for Standardization in Hematology</collab>
<article-title xml:lang="en"><![CDATA[Recommendation for measurement of serum iron in human blood]]></article-title>
<source><![CDATA[Brit J Haematol.]]></source>
<year>1978</year>
<volume>38</volume>
<page-range>291-294</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<collab>International Committee for Standardization in Hematology</collab>
<article-title xml:lang="en"><![CDATA[The measurement of total and saturated iron-binding capacity in serum]]></article-title>
<source><![CDATA[Brit J Haematol.]]></source>
<year>1978</year>
<volume>38</volume>
<page-range>281-290</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Flowers]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Kuizon]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Beard]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Skikne]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Covell]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Cook]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[A serum ferritin assay for prevalence studies of iron deficiency]]></article-title>
<source><![CDATA[Am J Hematol.]]></source>
<year>1986</year>
<volume>23</volume>
<page-range>141-151</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="book">
<collab>Diagnostic Product Corporation</collab>
<source><![CDATA[Dualcount Solid Phase No Boil Assay for Vitamin B12 and Folic Acid]]></source>
<year>1999</year>
<publisher-loc><![CDATA[California ]]></publisher-loc>
<publisher-name><![CDATA[Brochure included with the kit]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Suárez]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Torrealba]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Villegas]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Osorio]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[García-Casal]]></surname>
<given-names><![CDATA[MN]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Deficiencias de hierro, ácido fólico y vitamina B12 en relación a anemia, en adolescentes de una zona con alta incidencia de malformaciones congénitas en Venezuela]]></article-title>
<source><![CDATA[Arch Latinoam Nutr.]]></source>
<year>2005</year>
<volume>55</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>118-123</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hidalgo]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<source><![CDATA[ina A, anemia y antropometría nutricional en pre-escolares y escolares Piaroa, Estado Amazonas. (Vitamin A, anemia and nutritional anthropometrics in Piaroa preschoolers and scholars, Amazonas State)]]></source>
<year>2002</year>
<page-range>61-66</page-range><publisher-loc><![CDATA[Caracas ]]></publisher-loc>
<publisher-name><![CDATA[Universidad Simón Bolívar]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Diez-Ewald]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Torres-Guerra]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Leets]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Layrisse]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Vizcaíno]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Arteaga]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Anemia en poblaciones indígenas del Occidente Venezolano]]></article-title>
<source><![CDATA[Invest Clín.]]></source>
<year>1999</year>
<volume>40</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>191-202</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Diez-Ewald]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Torres-Guerra]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Leets]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Layrisse]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Vizcaíno]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Arteaga]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Prevalencia de anemia y deficiencias de hierro, ácido fólico y vitamina B12 en 2 comunidades Bari al oeste de Venezuela]]></article-title>
<source><![CDATA[Invest Clín.]]></source>
<year>1997</year>
<volume>38</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>191-201</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
